Chelation therapy for atherosclerotic cardiovascular disease.
CONCLUSIONS: There is currently insufficient evidence to determine the effectiveness or ineffectiveness of chelation therapy in improving clinical outcomes of people with atherosclerotic cardiovascular disease. More high-quality, randomised controlled trials are needed that assess the effects of chelation therapy on longevity and quality of life among people with atherosclerotic cardiovascular disease.
PMID: 32367513 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Villarruz-Sulit MV, Forster R, Dans AL, Tan FN, Sulit DV Tags: Cochrane Database Syst Rev Source Type: research
More News: Acetic Acid | Alternative and Complementary Therapies | Cardiology | Cardiovascular | Clinical Trials | Complementary Medicine | Coronary Heart Disease | Databases & Libraries | General Medicine | Heart | Heart Attack | Heart Disease | International Medicine & Public Health | Nurses | Nursing | Pain | Peripheral Vascular Disease (PVD) | Stroke | Study | WHO